Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-Paclitaxel vs Paclitaxel in Advanced Squamous NSCLC
NCT03262948Phase 3Unknown
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology
- Start
- Dec 2017
- Primary completion
- Oct 2019
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of paclitaxel albumin-bound in squamous cell carcinoma of the lung (LSCC), sponsored by CSPC ZhongQi Pharmaceutical Technology. Status: unknown.
02
Drugs
paclitaxel albumin-bound
03
Conditions
squamous cell carcinoma of the lung (LSCC)
Beyond the preview
Go deeper on NCT03262948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03262948.